Latest Growth Capital News

Greatland Resources delivered a robust start to FY26, reporting strong gold and copper production alongside significant cash flow and promising exploration results at Telfer.

Vault Minerals delivered a strong September quarter with record gold production and advancing key infrastructure upgrades, setting the stage for significant free cash flow growth in FY27.

Northern Star Resources reported steady gold production and disciplined costs in Q1 FY26, with the KCGM Mill Expansion project progressing on schedule for early FY27 commissioning. Despite minor operational disruptions, the company maintains its full-year guidance and a robust financial position.

Meeka Metals delivered a strong September quarter with gold production exceeding feasibility study forecasts and costs coming in below plan, underpinning confidence in the Murchison Gold Project’s growth trajectory.

Regis Resources reported a solid September quarter with 90.4koz gold production and a $158 million increase in cash and bullion. Key underground projects at Garden Well Main and Rosemont Stage 3 began ore production, supporting steady FY26 guidance.

Maas Group Holdings delivered a record $219.4 million Underlying EBITDA in FY25, driven by strategic acquisitions and disciplined capital recycling. The company projects further growth with FY26 EBITDA guidance between $240 million and $270 million amid stable market conditions and expanding renewable energy projects.

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

National Storage REIT delivered robust FY25 results, surpassing earnings guidance and expanding its development pipeline, while advancing sustainability and technology initiatives.

BCAL Diagnostics has launched a $10 million convertible note facility, with $5 million already committed, to strengthen its capital position and accelerate commercialisation of its cancer detection technologies.

XRF Scientific has reported a robust September quarter with a 16% increase in revenue, driven by strong international sales and new product launches. The company is poised for further expansion with ongoing innovation and strategic focus on global markets.

Bailador Technology Investments reported a robust FY25 with a 33% gross IRR from its private portfolio, $41 million deployed in new and follow-on investments, and a strong final dividend of 3.6 cents per share.